Harrow, Inc. Common Stock (HROW) Stock Price

HROWStock
$41.33+1.74%52W
Market Cap$1.55B
P/E
PEG Ratio
Div yield
Beta0.15

HROW Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-31.44%
Price vs S&P 500 (4W)-1.83%
VGM Score50.09

HROW Earnings Surprise History

Q2 250.24est. 0.04
Q3 250.03est. 0.26
Q1 26-0.74est. -0.33
Q2 26-0.46est. -0.24

HROW Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.29
4.29
4.29
4.29

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
HROWHarrow, Inc. Common Stock
DBC$41.33
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Harrow, Inc. Common Stock

Harrow Inc is a specialty pharmaceutical company that develops and commercializes ophthalmic medications for the U.S. market, including branded products like Iheezo, Vevye, and Maxitrol. The company generates revenue through its Branded segment and ImprimisRx platform, while advancing a clinical pipeline targeting conditions such as dry eye disease, glaucoma, and cataracts across both front and back-of-the-eye indications.